Molecular evaluation of hepatitis B virus infection and predominant mutations of pre-core, basal core promoter and S regions in an Iranian population with type 2 diabetes mellitus: a case–control study

• Published in: BMC infectious diseases 2022-06, Vol.22 (1), p.1-553, Article 553
• Main Authors: Farshadpour, Fatemeh, Taherkhani, Reza, Saberi, Fatemeh
• Format: Article
• Language: English
• Subjects: Age groups; Analysis; Antigens; Care and treatment; Deoxyribonucleic acid; Diabetes; Diabetes mellitus; Diabetes mellitus (non-insulin dependent); Diabetics; Diagnosis; DNA; Gene mutations; Gene sequencing; Genomes; Genotype; Genotypes; Health aspects; Hepatitis; Hepatitis associated antigen; Hepatitis B; Hepatitis B surface antigen; Hepatitis B virus; Infections; Infectious diseases; Laboratories; Males; Metabolism; Mutation; Patients; Planet detection; Polymerase chain reaction; Pre-core mutations; Prevalence; Promoters (Genetics); Risk factors; S mutations; Serology; Software; Testing; Viruses
• ISSN: 1471-2334; 1471-2334
• DOI: 10.1186/s12879-022-07528-7

This study was designed to evaluate the prevalence, genotypic patterns, and predominant mutations of hepatitis B virus (HBV) infection among diabetic patients. Serum samples were obtained from 733 patients with type 2 diabetes mellitus and 782 non-diabetic controls. The presence of HBsAg and HBcAb was determined by ELISA. Nested PCR, targeting S and pre-core regions of the HBV genome, followed by sequencing was carried out to determine HBV genotypes and predominant mutations in the S, basal core promoter (BCP), and pre-core regions of the HBV genome. Of 733 diabetic patients, 94 cases (12.82%) were positive for HBcAb, 28 cases (3.82%) were positive for HBsAg, and 19 cases (2.59%) had HBV-DNA with genotype D, sub-genotype D1/D3 and subtype ayw2. An occult HBV infection was found in one of the HBV DNA-positive samples, which was positive for HBcAb but negative for HBsAg. P120T/G145R, G1896A/G1899A, and A1762T/G1764T were the most frequent point substitution mutations detected in the S, pre-core, and BCP regions of the HBV genome, respectively. P120T and G145R mutations were associated with low levels or undetectable levels of HBsAg in serum. Therefore, routine tests based on HBsAg detection cannot detect HBsAg-negative infected patients. Relatively high prevalence of HBV infection was found in diabetic patients, while all of the HBV-infected patients were unaware of their infection. Therefore, screening for HBV infection should be included in the management program of diabetes for timely diagnosis and treatment of infected but asymptomatic patients.